The present and future of antifibrotic drugs - ERS Satellites 2025: Paediatric respiratory diseases, Asthma, COPD & ILD

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

ILD

Chair(s): Milan Sova, Athénaïs Boucly, Nazia Chaudhuri, Hilary Pinnock, Nicolas Roche

Session type: Session

The present and future of antifibrotic drugs

Maria Molina Molina

EVENTS HOME

Previous presentation

Next presentation

Session content

Introduction from the chairs in the Studio

Replay

Mechanisms of ILD in connective tissue disorders

Katerina Antoniou

Replay

The role of genes

Raphaël Borie

Replay

Hypersensitivity pneumonitis: the detective work (how we need to explore them to find the cause?

Michael Kreuter

Replay

The present and future of antifibrotic drugs

Maria Molina Molina

Replay

Conclusion and Q&As lead by the chairs in the Studio

Replay

ERS Satellites 2025